Development and characterization of a novel nano-liposomal formulation of Alendronate Sodium loaded with biodegradable polymer

ABSTRACT Background: Alendronate Sodium (ALDS) is the drug of choice for treatment of osteoporosis. However, 50% of the osteoporotic patients ceased the treatment within the first year due to its potential side effect on the gastrointestinal tract (GIT). Objective: The current study aimed to utilize...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heba F. Salem (Autor), Rasha M. Kharshoum (Autor), Mohamed Mahmoud (Autor), Saleh A. Azim (Autor), EL-Zeiny M. Ebeid (Autor)
Formato: Libro
Publicado: Facultad de Farmacia, Universidad de Granada.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible